Analyst firms · Raymond James · NTRA

Raymond James NTRA price target and rating history

Natera Inc. (NTRA) · Health Care

Raymond James rates Natera Inc. (NTRA) Outperform with a $85 price target, as of its latest action on Feb 20, 2024. It has published 3 rating actions on NTRA since January 2023, including 2 upgrades and 1 downgrade. Across 8 firms with a NTRA price target in the last 12 months, the median target is $305.

Current rating
Outperform
Price target
$85
Median target, all firms
$305
Actions on NTRA
3

Raymond James price target on NTRA

$85$72$58202420252026
Raymond James price target on NTRA, each point a stated target, January 2023 to February 2024.

Every Raymond James rating on NTRA

How other firms rate NTRA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Roth CapitalBuy$475Oct 23, 2026
UBSBuy$435Sep 9, 2026
Rothschild & Co RedburnBuy$385Sep 8, 2026
BernsteinOutperform$310Jun 26, 2026
RBC Capital MarketsOutperform$275Jun 12, 2026
Wolfe ResearchOutperform$260Jun 2, 2026
William BlairOutperformApr 14, 2026
CitigroupBuy$300Jan 7, 2026
Morgan StanleyOverweight$265Dec 2, 2025

Questions about Raymond James and NTRA

What is Raymond James's price target for NTRA?
Raymond James's latest stated price target for Natera Inc. (NTRA) is $85, from its action on Feb 20, 2024.
What is Raymond James's rating on NTRA?
Raymond James rates NTRA Outperform, a bullish rating, as of Feb 20, 2024.
When did Raymond James last change its view on NTRA?
On Feb 20, 2024, Raymond James downgrades to Outperform from Strong Buy, price target $68 to $85.
How does Raymond James's NTRA target compare with other analysts?
Across 8 firms with a NTRA price target in the last 12 months, the median target is $305.

More NTRA rating histories

All Raymond James ratingsNTRA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.